MEDIA ALERT: Codex DNA Customer to Highlight Advantages of Automated BioXp™ System in Precision Cancer Immunotherapy Applications at 13th Annual PEGS Europe Protein and Antibody Engineering Summit
01 nov. 2021 08h03 HE
|
Codex
San Diego, CA, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced that one of its customers will be...